Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(1507)
•••
Post by wildbird1on Mar 28, 2019 8:04am
123 Views
Post# 29546648

Telehealth Partners (with an ''s'')

Telehealth Partners (with an ''s'')PressRelease March 25, 2019...
GEN said (QUOTE) '' The funding will provide the company with the necessary finances to support new distribution agreements with Telehealth Partners'' (END of QUOTE).

Question? What is a Telehealth Partner?

A Telehealth Partner is a company that provide 24/7 remote access to multiple healthcare resources on a single, turnkey platform.
First time ever (to my knowledge) that GEN has signed agreements with multiples Telehealth Partners.

Question? Who are the clients of a big Telehealth Partner?
Big employer-sponsored health insurance...
Big health insurance network...
Big Healthcare systems...
Big medical practice...
Ect...

The beauty of it, is that GEN doesn't have to sign agreements with any of these clients, no, GEN just sign on with the big Telehealth Partners and GEN tests are made available to multiple big insurance network, multiple big HealthCare systems...Ect.

Some of these Telehealth Partners are huge.
The more you look at it, the more you realise that tests volume will definitively be rising.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities